BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Biosimilars
Artificial intelligence
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, March 28, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Oct. 27, 2017
View Archived Issues
Alzamend Neuro selects consultant to lead path to IND filing for CAO-22W
Read More
Amicrobe receives award from CARB-X to support development of Amicidin-beta
Read More
1st Biotherapeutics and Neuraly to jointly develop drugs for Parkinson's
Read More
MabSpace files Chinese IND for second-generation PD-L1 antibody MSB-2311
Read More
Heron Therapeutics' HTX-011 awarded FDA fast track designation
Read More
Achaogen submits plazomicin NDA in U.S.
Read More
Innovation Pharmaceuticals completes phase II trial of Brilacidin-OM
Read More
C12G6 demonstrates broad prophylactic and therapeutic activity in preclinical models of influenza B
Read More
Saniona will perform interim analysis of Tesomet study in Prader-Willi syndrome
Read More
Clinical results with autologous mesenchymal stem cell neural progenitors lead to phase II MS trial
Read More
FDA gives breakthrough therapy designation to valoctocogene roxaparvovec
Read More
Results from the ReBUILD study of clemastine fumarate as a remyelinating drug for multiple sclerosis
Read More
Vaxart reports results from phase II study of H1 influenza oral tablet vaccine
Read More
Risankizumab meets all co-primary endpoints in pivotal phase III psoriasis studies
Read More
GlaxoSmithKline patents hSTING modulators
Read More
PHSA and UILO divulge new AR modulators
Read More
Novel bromodomain inhibitors presented by AbbVie
Read More
Regentis Biomaterials identifies new conjugates for bone disorders
Read More
Toray Industries divulges antibodies to MCEMP1 for cancer
Read More
Japan Tobacco and Torii sign Japanese development and commercialization agreement for JTZ-951
Read More
Study confirms nonsedative effects of Neurana's skeletal muscle relaxant tolperisone
Read More
Incyte and MacroGenics announce collaboration and license agreement for MGA-012
Read More
FDA gives rare pediatric disease designation to Atara Biotherapeutics' ATA-230 for CMV
Read More
100% sensitivity of sentinel lymph node detection with [99mTc]Alotech in throat cancer
Read More
Enterome completes phase I study of EB-8018
Read More
PDL Biopharma submits another unsolicited proposal to acquire Neos Therapeutics
Read More
EMA validates mogamulizumab MAA for CTCL
Read More
European Commission approves new indication for Firazyr
Read More
FDA approves intravenous Varubi for delayed nausea and vomiting associated with chemotherapy
Read More
Transgene treats first patient in first-in-human study of TG-6002
Read More
Chugai profiles developments of third quarter 2017
Read More